Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Michel Kuzur

Dr. Michel Kuzur

Medical Oncologist

Dr. Michel E. Kuzur at Tennessee Oncology is one of the most experienced medical oncologists in Nashville. He is well known for taking great care of patients with his old-fashioned, personalized approach to medicine.

Get in touch
Jump to a Topic:

About Michel Kuzur

  • Board Certified icon

    Board Certified in Radiation Oncology

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

Get to Know Dr. Michel E. Kuzur

Medical oncologist Dr. Michel E. Kuzur has been caring for cancer patients for four decades, combining his vast experience with the latest clinical research to provide first-rate, personalized treatment for his patients.

Since 1994, Kuzur has been with Tennessee Oncology, one of the country’s largest community based cancer-care groups. The group has a growing network of top-level physicians.

Kuzur sees patients at the TriStar Skyline Medical Center and the TriStar Centennial Medical Center in Nashville. He treats many different adult malignancies, including lung cancer, mesothelioma, kidney cancer, prostate cancer and Hodgkin’s lymphoma.

He has been practicing medicine since 1981 and has played a key role in Tennessee Oncology’s reputation for high-quality care and expertise in clinical research.

Specialties of Dr. Michel E. Kuzur

  • Medical oncology
  • Hematology
  • Lung cancer
  • Chemotherapy
  • Bone marrow biopsies

Dr. Michel E. Kuzur’s Experience and Medical Education

  • Tennessee Oncology
  • Miller Medical Group
  • University of Massachusetts Memorial Hospital (Residency)
  • Vanderbilt University Medical Center (Fellowship)
  • American University of Beirut (Internship and medical degree)

Awards and Other Recognitions

  • Patients’ Choice Award
  • Nashville Academy of Medicine (Member)
  • American Society of Clinical Oncology (Member)
  • American Society of Hematology (Member)

See More Top Mesothelioma Doctors

Publications of Dr. Michel E. Kuzur

  • Bendell, J. et al. (2017, April). A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer. Cancer Investigation.
  • Kuzur, M. et al. (2005, June). Paclitaxel, carboplatin, and gemcitabine (PCG) versus gemcitabine and vinorelbine (GV) in chemotherapy naïve patients (pts) with advanced non-small cell lung cancer (NSCLC): A phase III trial of the Minnie Pearl Cancer Research Network (MPCRN). Journal of Clinical Oncology.

Disclaimer: Dr. Michel Kuzur has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Tennessee Oncology. (n.d.). Michel E. Kuzur, M.D. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 28, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now